[1] CHEN H,SAHIN A,LU X,et al.23-Assessment of Breast Cancer With Borderline HER2,Status Using MIP Microarray[J].Cancer Genetics,2017,214(5):39.
[2] MA SY,PARK JH,JUNG H,et al.Snail maintains metastatic potential,cancer stem-like properties,and chemoresistance in mesenchymal mouse breast cancer TUBO-P2J cells[J].Oncol Rep,2017,35(2):36.
[3] Srivastava JK,PILLAI GG,BHAT HR,et al.Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase[J].Sci Rep,2017,7(1):5851.
[4] 汪瑞,周军,沈俊,等.核磁共振在乳腺癌中的诊断价值[J].影像研究与医学应用,2017,1(2):53.
[5] 李尊严,于士龙,郑亮亮,等.血清P16自身抗体作为潜在的乳腺癌早期诊断标志物研究[J].中国地方病防治杂志,2017,32(2):159.
[6] 张巨彪,苏秀兰,欧阳晓晖.联合检测血清肿瘤标志物对乳腺癌的诊断价值[J].疾病监测与控制,2017,11(6):448.
[7] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2013版)[J].中国癌症杂志,2013,23(8):637.
[8] JUNG SY,ROSENZWEIG M,SEREIKA SM,et al.Factors associated with mortality after breast cancer metastasis[J].Cancer Causes Control,2012,23(1):103.
[9] 周静,朱宇熹.多肿瘤标志物蛋白芯片检测对乳腺癌新辅助化疗的临床价值[J].重庆医学,2015,44(5):665.
[10] LI Y,WANG Y,SONG Y,et al.Controlled synthesis and luminescence properties of GdF3 with different crystalline phases and morphologies[J].Crystengcomm,2017,19(11):19.
[11] GUAN H,XU C,SHENG Y,et al.Controlling the Morphology and Size of GdF3:RE3+(RE=Dy,Tb,and Sm) by pH Value:Growth Mechanism,Energy Transfer,and Luminescent Properties[J].J Phys Chem C,2017,121(12):23.
[12] PEDERSEN AC,SORENSEN PD,JACOBSEN EH,et al.Sensitivity of CA15-3,CEA and serum HER2 in the early detection of recurrence of breast cancer[J].Clin Chem Lab Med,2013,51(7):1511.
[13] 李继广,任更朴,蔡庆岭.CA153,CA125与细针吸取细胞学联检在乳腺癌诊断中的应用价值[J].中国实用医刊,2012,38(2):1.
[14] LAKHANI SR,ELLIS IO,SEHNITT SJ,et al.WHO classification of tumoursof the breast[M].France:IARC Press,2012:100.
[15] 张宏宾,白梅,赵连儒,等.新辅助化疗对乳腺癌患者血清GDF3、TK1、CA15-3及CEA水平的影响[J].临床合理用药杂志,2015,8(25):87.
[16] 黄春军,张海,吴旻华,等.注射用曲妥珠单抗对局部晚期乳腺癌患者的疗效及相关指标的影响[J].中国生化药物杂志,2017,37(3):178.
[17] 孙听,李嘉嘉,王道斌.乳腺癌生物标志物CK19、HER2和血清CEA、CA153 联合检测的临床意义[J].中国医药科学,2013,3(8):37.
[18] 王琼,胡建军,李艳霞.人生长分化因子3、前列腺特异性抗原与黏蛋白1联合检测在乳腺癌诊断中的临床意义[J].中国生化药物杂志,2017,37(5):388.
[19] 孙小涵,曹勤,肖建英.血清肿瘤标志物和细胞因子在乳腺癌检测中的临床意义研究[J].海南医学院学报,2017,23(2):197.
[20] 邱小兰,韩学东,施建华,等.GDF3联合检测血清PSA与MUC1蛋白水平对乳腺癌诊断的临床意义[J].河北医学,2016,22(12):2026.